(COPE ID 96221-PH, 0.5 hr)

Dr. Sam Valley, who holds both an OD and PharmD degree, discusses the role of eye care providers in diabetes management, emphasizing inter-professional communication and continuity of care. Key points include the common use of metformin for type 2 diabetes, its adverse effects like nausea, and strategies to improve patient adherence. Sulfonylureas, such as glipizide, glyburide, and glimepiride, were highlighted for their risk of hypoglycemia. GLP-1 agonists, like ozempic, were discussed for their effectiveness in controlling blood glucose and reducing cardiovascular risks, despite potential ocular side effects. The importance of monitoring patients on these medications was stressed, especially for those using them for weight loss.